Topic archive

psylabs

9 stories

10/21/2026

Psyence BioMed finalizes $2.6M investment in PsyLabs

Psyence BioMed invests in PsyLabs following milestone achievements.

10/21/2026

Investment completion coincides with key ibogaine research milestones.

10/5/2026

Psyence BioMed partners with Benuvia for U.S. ibogaine production, aiming to advance clinical research.

9/28/2026

Psyence BioMed and PsyLabs collaborate on ibogaine licensing agreement.

9/14/2026

Texas Ibogaine Research Corporation to spearhead U.S. ibogaine development efforts.

8/19/2026

U.S. federal actions could accelerate ibogaine's medical potential

8/19/2026

Company aligns with U.S. efforts to advance ibogaine research.

8/8/2026

The biotech firm aims for vertical integration in psychedelic therapeutics.

8/7/2026

Psyence Biomedical outlines its focus on psychedelic therapeutics for mental health in a recent investor update.